Xenon Pharmaceuticals Inc.NASDAQ: XENE

Xenon Pharmaceuticals Presents Additional Positive Data from Phase 2b ‘X-TOLE’ Clinical Trial at the Annual Meeting of the American Epilepsy Society (AES 2021)

· Issued by Xenon Pharmaceuticals Inc.
Watch Xenon Pharmaceuticals explain itXenon Pharmaceuticals Inc. (XENE) Q2 2026 Earnings Call · Replay · Aug 6

Topline Data Showed All Primary and Secondary Seizure Reduction Endpoints Statistically Significant Across All Dose Groups, with p-value of